Sobey C G, Faraci F M
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242, USA.
Stroke. 1997 Apr;28(4):837-42; discussion 842-3. doi: 10.1161/01.str.28.4.837.
Nitric oxide-induced vasodilatation is mediated by both cGMP-dependent and -independent mechanisms. Previous studies that examined the role of soluble guanylyl cyclase in cerebral vessels have used methylene blue and LY-83583, compounds that generate superoxide anion and are not specific for inhibition of soluble guanylyl cyclase. We examined the effects of ODQ (1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one), a novel and highly selective inhibitor of soluble guanylyl cyclase, on responses of cerebral arterioles.
The effects of ODQ on responses of cerebral arterioles to acetylcholine, nitroprusside, 8-bromo-cGMP, and adenosine were examined in anesthetized mice by means of a cranial window. The effects of two concentrations of ODQ were examined in the absence and presence of superoxide dismutase. The effects of NG-nitro-L-arginine, an inhibitor of nitric oxide synthase, were also tested.
ODQ (3 and 10 mumol/L) produced concentration-dependent inhibition of dilatation of cerebral arterioles (control diameter = 29 +/- 1 microns) (mean +/- SE) in response to acetylcholine and nitroprusside. For example, 10 mumol/L acetylcholine and 1 mumol/L nitroprusside dilated cerebral arterioles by 28 +/- 3% and 44 +/- 2% in the absence and 6 +/- 2% and 7 +/- 1%, respectively, in the presence of 10 mumol/L ODQ (P < .05 versus control). The inhibitory effects of ODQ were not altered by superoxide dismutase. Vasodilatation in response to 8-bromo-cGMP and adenosine was not inhibited by ODQ. NG-Nitro-L-arginine (100 mumol/L), an inhibitor of nitric oxide synthase, inhibited responses to acetylcholine by approximately 80% but tended to enhance responses to nitroprusside.
Thus, nitric oxide-mediated dilatation of mouse cerebral arterioles is profoundly inhibited by ODQ, an inhibitor of activity of soluble guanylyl cyclase. Cerebral vasodilator responses to adenosine and 8-bromo-cGMP were preserved in the presence of ODQ, indicating that inhibition by ODQ was selective. In contrast to previously used inhibitors of soluble guanylyl cyclase (methylene blue and LY-83583), the effects of ODQ are not mediated by generation of superoxide anion.
一氧化氮诱导的血管舒张由依赖环磷酸鸟苷(cGMP)和不依赖cGMP的机制介导。以往研究可溶性鸟苷酸环化酶在脑血管中作用时,使用了亚甲蓝和LY - 83583,这些化合物会产生超氧阴离子,并非特异性抑制可溶性鸟苷酸环化酶。我们研究了新型高选择性可溶性鸟苷酸环化酶抑制剂ODQ(1H - [1,2,4]恶二唑并[4,3,-a]喹喔啉 - 1 - 酮)对脑小动脉反应的影响。
通过颅窗在麻醉小鼠中研究ODQ对脑小动脉对乙酰胆碱、硝普钠、8 - 溴 - cGMP和腺苷反应的影响。在有无超氧化物歧化酶的情况下检测了两种浓度的ODQ的作用。还测试了一氧化氮合酶抑制剂NG - 硝基 - L - 精氨酸的作用。
ODQ(3和10 μmol/L)对脑小动脉(对照直径 = 29 ± 1微米)(平均值 ± 标准误)对乙酰胆碱和硝普钠的舒张反应产生浓度依赖性抑制。例如,在无10 μmol/L ODQ时,10 μmol/L乙酰胆碱和1 μmol/L硝普钠使脑小动脉分别舒张28 ± 3%和44 ± 2%,而在有10 μmol/L ODQ时分别为6 ± 2%和7 ± 1%(与对照相比,P < 0.05)。ODQ的抑制作用不受超氧化物歧化酶影响。ODQ不抑制对8 - 溴 - cGMP和腺苷的血管舒张反应。一氧化氮合酶抑制剂NG - 硝基 - L - 精氨酸(100 μmol/L)使对乙酰胆碱的反应抑制约80%,但倾向于增强对硝普钠的反应。
因此,可溶性鸟苷酸环化酶活性抑制剂ODQ可显著抑制小鼠脑小动脉中一氧化氮介导的舒张。在有ODQ存在时,对腺苷和8 - 溴 - cGMP的脑血管舒张反应得以保留,表明ODQ的抑制作用具有选择性。与先前使用的可溶性鸟苷酸环化酶抑制剂(亚甲蓝和LY - 83583)不同,ODQ的作用不是由超氧阴离子的产生介导的。